Skip to content

Study · Measured the body's own peptide · 2001

1 result

High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas.

Nishie A, Masuda K, Otsubo M, Migita T, Tsuneyoshi M, Kohno K, Shuin T, Naito S, Ono M, Kuwano M

Clinical cancer research : an official journal of the American Association for Cancer Research1 Jul 2001Cited by 41 (Europe PMC)

PMID11448934 (opens in a new tab)PepBankPUB-11448934
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In human renal cell carcinoma, thymosin beta4 was among nine genes with increased expression in the cancerous region compared with the noncancerous region.

    In plain wordsIn human kidney cancer tissue, the body's own thymosin beta4 gene was more active in cancer than in nearby healthy tissue.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseTbeta4 expression in cancerous renal tissue
    Study

    n: not reported in source

    Comparator
    Noncancerous tissue
    Outcome group
    Gene expression · Cancer

    Source sentences

    Summary
    Nine genes were identified to show increased expression in the cancerous region compared with the noncancerous region. The nine genes included thymosin beta4, secreted protein acidic and rich in cysteine (SPARC), Cap43, ceruloplasmin, serum amyloid A, osteopontin, heat shock protein 90 (HSP90), LOT1…
    1 context sentence
    Summary · context
    We used suppression subtractive hybridization to identify highly expressed genes in the cancerous region of human renal cell carcinoma (RCC) compared with noncancerous tissue.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.